EC1169
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EC1169, covering 2019-02-07 to 2019-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 of EC1169 In Patients With Recurrent MCRPC [Phase 1]